COVID-19 - March 15, 2021
Finnish nasal COVID-19 vaccine to be launched
A newly-founded Finnish academic spin-out is working to develop and introduce to the markets a nasal spray vaccine against COVID-19. The vaccine is based on research at the University of Helsinki and the University of Eastern Finland and the new company is called Rokote Laboratories Finland. The founders and board members of the company are […]
COVID-19 - March 12, 2021
Johnson & Johnson’s vaccine granted conditional marketing authorization in the EU
The European Commission has granted a Conditional Marketing Authorization for the company’s single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The CMA follows a Positive Opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). The CMA is valid in all 27 member states […]
COVID-19 - March 9, 2021
Danish vaccine candidate approved for phase 1 testing on humans
A COVID-19 vaccine candidate developed at the University of Copenhagen has been approved for phase 1 testing on humans. The vaccine is developed by a team of researchers at the University of Copenhagen in collaboration with the companies AdaptVac, ExpreS2ion Biotechnologies and Bavarian Nordic. The vaccine candidate, ABNCoV2, has now been approved for human clinical […]
COVID-19 - March 3, 2021
Newborn infected with COVID-19 in the mother’s womb
A baby born at Skåne University Hospital, Sweden, last year tested positive for COVID-19 and a study of the case has now established that the baby was already infected whilst in the mother’s womb. The new study provides answers to several important questions on how both mothers and babies can be affected by the infection. […]
COVID-19 - March 3, 2021
AstraZeneca and Serum Institute of India will be the biggest initial supplier to COVAX
AstraZeneca advances mass global rollout of COVID-19 vaccine through the multilateral COVAX initiative. Supply to 142 countries is underway as part of the effort to bring broad and equitable access to the vaccine, the company states in a press release. “These first steps towards fulfilling our broad, equitable and no-profit emergency response to the pandemic […]
COVID-19 - March 2, 2021
Despite the pandemic, many Swedish life science companies are in growth mode
A new survey by SwedenBIO shows that Swedish life science companies are even more confident about future growth compared to pre-COVID. A similar report was published exactly one year ago and the two surveys demonstrate the remarkable strength and resilience of the sector, states SwedenBIO in its press release. “Despite the pandemic, the situation has […]
